Urinary extracellular vesicle protein profiling and endogenous lithium clearance support excessive renal sodium wasting and water reabsorption in thiazide induced hyponatremia by Channavajjhala, Sarath K. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Urinary extracellular vesicle protein profiling and endogenous
lithium clearance support excessive renal sodium wasting and
water reabsorption in thiazide induced hyponatremia
Citation for published version:
Channavajjhala, SK, Bramley, R, Peltz, T, Oosthuyzen, W, Jia, W, Kinnear, S, Sampson, B, Martin, N, Hall,
IP, Bailey, MA, Dear, JW & Glover, M 2018, 'Urinary extracellular vesicle protein profiling and endogenous
lithium clearance support excessive renal sodium wasting and water reabsorption in thiazide induced
hyponatremia' Kidney International Reports. DOI: 10.1016/j.ekir.2018.09.011
Digital Object Identifier (DOI):
10.1016/j.ekir.2018.09.011
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Kidney International Reports
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Accepted Manuscript
Urinary extracellular vesicle protein profiling and endogenous lithium clearance
support excessive renal sodium wasting and water reabsorption in thiazide induced
hyponatremia
Sarath K. Channavajjhala, PhD, Roger Bramley, Theresa Peltz, Wilna Oosthuyzen,
PhD, Wenjing Jia, PhD, Sue Kinnear, RN, Barry Sampson, Nick Martin, Ian P. Hall,
MB BCh DM, Matthew A. Bailey, PhD, James W. Dear, BM BCh PhD, Mark Glover,
MB BChir PhD
PII: S2468-0249(18)30211-0
DOI: 10.1016/j.ekir.2018.09.011
Reference: EKIR 426
To appear in: Kidney International Reports
Received Date: 6 June 2018
Revised Date: 22 August 2018
Accepted Date: 17 September 2018
Please cite this article as: Channavajjhala SK, Bramley R, Peltz T, Oosthuyzen W, Jia W, Kinnear S,
Sampson B, Martin N, Hall IP, Bailey MA, Dear JW, Glover M, Urinary extracellular vesicle protein
profiling and endogenous lithium clearance support excessive renal sodium wasting and water
reabsorption in thiazide induced hyponatremia, Kidney International Reports (2018), doi: https://
doi.org/10.1016/j.ekir.2018.09.011.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
0 
 
Urinary extracellular vesicle protein profiling and 
endogenous lithium clearance support excessive 
renal sodium wasting and water reabsorption in 
thiazide induced hyponatremia 
Running Title: Urinary extracellular vesicles and lithium in TIH  
 
Authors: Sarath K. Channavajjhala PhD*1,2, Roger Bramley3, Theresa Peltz4, Wilna 
Oosthuyzen PhD4, Wenjing Jia PhD1,2, Sue Kinnear RN1,2, Barry Sampson3, Nick 
Martin3, Ian P. Hall MB BCh DM1,2, Matthew A Bailey PhD4, James W Dear BM BCh 
PhD4 and Mark Glover MB BChir PhD1,2 
 
Affiliation: (1) Division of Therapeutics and Molecular Medicine, University of 
Nottingham, Nottingham, United Kingdom, (2) NIHR- Nottingham Biomedical Research 
Centre, (3) Trace Element Laboratory, Imperial College Healthcare NHS Trust, Charing 
Cross Hospital, London, (4) BHF Centre for Cardiovascular Science, University of 
Edinburgh 
 
Correspondence to: Dr M. Glover, Division of Therapeutics and Molecular Medicine, 
Queen’s Medical Centre, Nottingham, NG7 2UH, UK. 
 
 
E-mail: mark.glover@nottingham.ac.uk 
Tel: +44 115 8231063 
Fax: +44 115 8231059 
 
Abstract word count: 249 (1508 characters) 
Text characters: 33920 characters 
 
 
Sources of support: Medical Research Council
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
1 
 
Abstract 1 
Introduction: Thiazide diuretics are amongst the most widely used anti-hypertensive 2 
medicines worldwide. Thiazide-Induced Hyponatremia (TIH) is one of their most 3 
clinically significant adverse effects. A priori TIH must result from excessive saliuresis 4 
and/or water reabsorption. We hypothesised that pathways regulating the thiazide-5 
sensitive NCC and the water channel AQP2 may be involved. Our aim was to assess 6 
whether patients with TIH show evidence of altered NCC and AQP2 expression in 7 
urinary extracellular vesicles (UEVs), and also whether abnormalities of renal sodium 8 
reabsorption were evident using Endogenous Lithium Clearance (ELC). 9 
Methods: Blood and urine samples were donated by patients admitted to hospital with 10 
acute symptomatic TIH, after recovery to normonatremia, and also from normonatremic 11 
controls on and off thiazides. UEVs were isolated and target proteins evaluated by 12 
Western blotting and by Nanoparticle Tracking Analysis (NTA). ELC was assessed by 13 
Inductively Coupled Plasma Mass Spectrometry. 14 
Results: UEVs analysis by Western blotting showed that patients with acute TIH display 15 
reduced total NCC and increased phospho-NCC and AQP2 relative to appropriate 16 
control groups; smaller differences in NCC and AQP2 expression persisted after 17 
recovery from TIH. These findings were confirmed by NTA. Renal ELC was lower in 18 
acute TIH compared to controls and convalescent cases.  19 
Conclusion: Reduced NCC expression and increased AQP2 expression would be 20 
expected to result in saliuresis and water reabsorption in TIH patients. This study raises 21 
the possibility that UEV analysis may be of diagnostic utility in less clear cut cases of 22 
thiazide associated hyponatremia and may help identify those at risk of TIH before 23 
thiazide initiation.  24 
Keywords 25 
1. Thiazide 26 
2. Diuretic 27 
3. Sodium 28 
4. Hyponatremia 29 
5. Hypertension 30 
6. Urinary extracellular vesicles 31 
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Introduction 1 
Thiazide diuretics have been used in the management of hypertension for more than 2 
half a century1. They lower blood pressure by inhibition of the sodium-chloride 3 
cotransporter, NCC, in the Distal Convoluted Tubule (DCT) and have all-cause mortality 4 
benefits equivalent to ACE inhibitors and calcium channel antagonists1,2.  Although 5 
thiazides are generally well tolerated, their use is limited in a minority of patients due to 6 
hyponatremia3. Owing to the very large number of patients prescribed thiazides, 7 
Thiazide Induced Hyponatremia (TIH) is the most common cause of drug-induced 8 
hyponatremia requiring hospitalization4,5.  9 
 10 
The mechanisms underlying TIH remain unclear. Risk factors for TIH include advanced 11 
age, reduced body mass and concurrent use of other medications which impair water 12 
excretion6. A priori TIH must result from excessive saliuresis and / or water reabsorption 13 
(or ingestion). It therefore seems likely that excessive saliuresis and / or water 14 
reabsorption (or ingestion) occurs via altered regulation of NCC and/or AQP2. As 15 
thiazide diuretics have not, to the best of our knowledge, been reported to produce 16 
saliuresis with a urinary sodium concentration greater than plasma, this suggests that 17 
excessive water reabsorption (or ingestion) is a fundamental part of the pathogenesis of 18 
TIH. Our aim in this study was to probe the molecular mechanisms underlying TIH by 19 
investigating whether patients with TIH exhibit evidence of altered regulation of NCC 20 
and AQP2.  21 
 22 
NCC is located in the renal cortex, therefore thiazides reduce maximal urinary diluting 23 
ability by increasing sodium excretion without affecting the renal medullary sodium 24 
gradient required for water reabsorption from the collecting duct7. NCC exists in three 25 
isoforms8. NCC1&2 vary by only 1 amino acid8. NCC3 however is 9 amino acids longer; it 26 
constitutes approximately 40% of NCC is the human nephron. NCC regulation occurs 27 
principally by two mechanisms: regulation of apical membrane abundance (Type 1 28 
regulation) and regulation of transporter kinetics (Type 2 regulation), the latter being 29 
controlled by phosphorylation of key N-terminal serine and threonine residues (Thr 60, 30 
Thr 55 and Ser 91)9,10. Urinary concentration principally occurs through the vasopressin-31 
AQP2 pathway in the collecting duct11-13. Moreover, microperfusion studies suggest 32 
thiazides may induce upregulation of aquaporin-2 (AQP2), increasing the water 33 
permeability of the collecting duct14,15. Locally derived Prostaglandin E2 (PGE2) is a key 34 
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modulator of this pathway16,17 and its reuptake into collecting duct cells is determined by 1 
a PGE2 specific ProstaGlandin Transporter (PGT). A recent study has suggested 2 
modest genetic associations with TIH including aberrant PGE2 reuptake in the distal 3 
nephron which may increase AQP2-mediated water reabsorption in a subset of patients 4 
who carry a variant within SLCO2A1, the gene encoding PGT18. 5 
 6 
Urinary Extracellular Vesicles (UEVs) are spherical, structured membrane vesicles 7 
which are formed by cells throughout the nephron19. Because UEVs contain cell derived 8 
membrane transporters and channels, their analysis is an attractive and non-invasive 9 
method to study renal tubular pathophysiology in patients 20-22.  10 
 11 
Since lithium is absorbed along with sodium throughout the nephron it is possible to use 12 
measurement of lithium clearance to assess tubular sodium reabsorption. Renal lithium 13 
clearance likely reflects mostly proximal tubular sodium reabsorption because this is 14 
where the majority of sodium is reabsorbed23. Measuring Endogenous Lithium 15 
Clearance (ELC) is preferable to exogenous lithium clearance following ingestion of 16 
lithium tablets, since it negates any potential effect which therapeutic doses of lithium 17 
may have on distal nephron physiology including water trafficking24 and is also more 18 
convenient for research volunteers. 19 
 20 
To fulfil our aim of investigating whether patients with TIH exhibit evidence of altered 21 
regulation of NCC and AQP2 we report analysis of urinary extracellular vesicle NCC and 22 
AQP2 in TIH patients and controls. We also report assessment of renal tubular sodium 23 
reabsorption in TIH patients by measurement of endogenous lithium clearance. 24 
 25 
Methods 26 
Clinical recruitment 27 
This study was conducted in line with the standards of ICH/Good Clinical Practise 28 
sections 8.2.8 in adherence to the Declaration of Helsinki and was approved by the UK 29 
national research ethics committee (reference 11/EM/0233). Informed consent was 30 
given by all participants. Between April 2012 and August 2015 a daily search of the 31 
biochemistry data base of all patients admitted to the department of internal medicine at 32 
Nottingham University Hospitals NHS Trust, UK was undertaken to identify those 33 
patients with serum sodium <130mM (cases). Patients were reviewed by the 34 
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investigators to establish those whose hyponatremia was due to a thiazide diuretic 1 
(TIH). Normonatremic thiazide and non-thiazide controls (serum sodium 135-145 mM) 2 
were identified by primary care surgeries in Nottinghamshire and matched as closely as 3 
possible to the cases for age, sex, comorbidities and polypharmacy. TIH cases were 4 
also assessed in the outpatient clinic two months after thiazide cessation (termed 5 
normonatremic TIH cases off thiazides). The cases here were a subset of those 6 
previously reported18 and are composed of the small number of acutely hyponatremic 7 
TIH patients who were able to produce a mid-morning spot urine sample suitable for the 8 
current study.   9 
 10 
Urine collection and processing 11 
Second morning spot urine samples (30ml) were collected in sterile containers from TIH 12 
patients and control groups (Supplementary Table 1). Protease inhibitor cocktail tablets 13 
(Roche Diagnostics) were added to urine samples immediately following collection and 14 
samples stored at -800C. Fresh urine samples were processed the same day.  15 
 16 
UEV isolation and total protein estimation 17 
Urinary nanovesicles, including UEVs were isolated from both fresh and frozen urine by 18 
Ultrafiltration (Vivaspin 20 MWCO 100 kDa - Sartorius Stedim, UK). Before processing 19 
of urine samples, nanomembrane concentrators were washed with PBS buffer to 20 
remove glycerol and other preservatives and then centrifuged at 2500 g for 5 min at RT. 21 
Frozen urine samples were thawed on ice, 1ml DTT (100 mg/ml final concentration) was 22 
added, extensively vortexed and incubated for 30 mins at 37°C before UEVs isolation. 23 
All samples were centrifuged (2500 g for 15 min at 4oC) for urinary cells removal. Cell 24 
pellet (CP) was suspended in lysis buffer (1.5% SDS and 50 mM Tris-HCl with protease 25 
inhibitor, pH 6.8) and stored at -800C. Further filtration of supernatant using 0.22 µm 26 
filters (Millipore, UK) was undertaken to remove debris. 25 mL of filtered supernatant 27 
was centrifuged at 15000 g for 30 min at 4°C. The u rine supernatants were then added 28 
to Vivaspin nanomembrane concentrators and centrifuged at 4800 g for 1 h. at 4° C. 29 
Concentrated UEVs were treated with 50 µl DTT, added directly in to the filters and 30 
incubated for 10 min at 37° C. Isolated urinary ext racellular vesicles were directly 31 
suspended in lysis buffer and stored at -800C. Total urine (TU) and flow through (FT) 32 
fractions were also stored at -800C and -200C. Total soluble protein concentration was 33 
quantified with BCA assay (Pierce®, Thermo Scientific, UK). 34 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
5 
 
 1 
Electrophoresis and Western immunoblotting 2 
25µg total soluble protein per sample was electrophoresed on 7.5 % (NCC and PNCC), 10% 3 
(ALIX and PGT) and 12.5% (AQP2) acrylamide gels. SDS-PAGE was performed on PVDF 4 
membrane (Bio-Rad, UK). UEVs AQP2 was detected by probing the blots with 1:500 diluted 5 
anti-AQP2 antibody (Sigma, UK) followed by anti-rabbit IgG HRP-conjugated antibody 6 
(Sigma, UK). UEVs NCC3 was probed with 1:500 diluted anti-NCC primary antibody 7 
(Millipore, UK) followed by anti-rabbit IgG HRP-conjugated antibody (Sigma, UK). UEVs 8 
NCC1&2 was probed with 1:500 diluted anti-NCC primary antibody (21st Century Biochemicals, 9 
USA) followed by anti-rabbit IgG HRP-conjugated antibody (Sigma, UK). UEVs PNCC 10 
(phosphorylated at T55, T60 and S91) was detected by probing blots with anti-PNCC 11 
antibodies (University of Dundee, UK), each at 1:500 (0.2–1.2 µg/ml) followed by anti-sheep 12 
IgG HRP-conjugated antibody (Sigma, UK). To detect specific phosphorylated forms of NCC, 13 
the corresponding nonphosphorylated peptide was incubated with primary antibody (10 14 
µg/ml). UEVs PGT was probed with 1:200 diluted anti-PGT primary antibody (Cayman, UK) 15 
followed by anti-rabbit IgG HRP-conjugated antibody (Sigma, UK). The anti- AQP2 and NCC 16 
antibodies used target intracellular domains of AQP2 and NCC. Vesicles did not undergo 17 
prior permeabilisation. Urinary cell pellet was used as a negative control for Western blots.  18 
UEVs ALIX was detected by probing the blots with 1:1000 diluted anti-ALIX antibody (Abcam, 19 
UK) followed by anti-rabbit IgG HRP-conjugated antibody (Sigma, UK). Western blot data 20 
were corrected for ALIX as indicated the relevant figure legends. This method of correction 21 
by ALIX is as previously reported27. The immunocomplex was detected by ECL 22 
chemiluminescence (GE Healthcare, UK) on X-Omat AR films (Kodak, UK). Normalization 23 
was carried using UEVs ALIX and bands were quantified using Image J® software. Density of 24 
each band was divided by the band from the same sample stained with amido black. The 25 
differential expression of UEVs proteins densitometry values among all different groups was 26 
evaluated by using one-way ANOVA followed by Tukeys multiple comparison tests (Graph 27 
Pad Prism V6.05). P < 0.05 was considered significant.  28 
Nanoparticle Tracking Analysis 29 
NTA is a light-scatter microscopy method of tracking microparticles and nanoparticles on the 30 
basis of direct and real-time tracking of the particles Brownian movement, which results in a 31 
description of the particle size and concentration distribution in a given solution. NTA can be 32 
used to count and measure specific subgroups of nanoparticles using fluorescent antibodies 33 
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against nanoparticle proteins, including extracellular vesicles derived from kidney cells in 1 
culture and in urine25.  2 
AQP2 and NCC-expressing UEVs were analyzed using the NanoSight LM 10 instrument 3 
(NanoSight Ltd, Amesbury, United Kingdom). The analysis settings were optimized and kept 4 
constant between samples, and each video was analyzed to give the mean, mode, median, 5 
and estimated concentration for each particle size. All experiments were carried out at a 6 
1:1000 dilution of unprocessed urine, yielding particle concentrations in the region of 1.3x108 7 
particles/ml in accordance with the manufacturer’s recommendations. For fluorescent NTA 8 
analysis, a 532-nm (green) laser diode excited the fluorescent-loaded ECVs with a long-pass 9 
filter (430 nm). For quantification of AQP2 (Miilipore, Billerica, MA, USA and NCC (Chemicon 10 
USA), primary antibodies were fluorescent-labeled by conjugation to Quantum dots. All 11 
samples were analyzed in triplicate to give one value per patient. NCC and AQP2 data were 12 
normalised by urinary creatinine. 13 
Endogenous Lithium measurement 14 
Serum and urine samples were prepared for analysis with a 1:25 dilution in 0.5% nitric acid 15 
(Romil, Cambridge, UK) containing 0.05% Triton-X 100 (Romil, Cambridge, UK) and 16 
40ng/mL beryllium (Alfa Aesar, Massachusetts, USA) as an internal standard.  17 
Measurements were performed on an Agilent 7900 ICP-MS (Agilent Technologies, USA) 18 
operated in no-gas mode with the RF generator power set to 950W giving a “cold” plasma.  19 
Lithium was measured at m/z ratio of 7 and was normailsed to the beryllium internal standard 20 
at m/z 9.  Calibration solutions were prepared by diluting a 1000 ug/mL lithium standard (Alfa 21 
Aesar, Massachusetts, USA) in 2% nitric acid (Romil, Cambridge, UK) to give concentrations 22 
of 0.0352, 0.141, 0.563, 2.25, 9 and 36 umol/L.  Seronorm trace elements urine quality 23 
control materials (Sero, Billingstad, Norway) and an in-house serum control were analysed in 24 
each batch. 25 
 26 
Results  27 
UEV characterization and validation 28 
 29 
Western blot analysis of AQP2, NCC3 and PGT was undertaken in healthy volunteers to 30 
establish (a) the principal urinary fraction(s) these transporters are excreted in (urinary 31 
extracellular vesicles (UEVs), Cell Pellet (CP) or Total Urine (TU)) and (b) the optimal 32 
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method of storage of urine samples for UEVs analysis (fresh vs. frozen urine stored at 1 
either -20oC or -80oC).  2 
 3 
The abundance of AQP2, NCC3 and PGT was much greater in UEVs than either CP or 4 
TU, confirming that UEVs are the most appropriate fraction of urine to study (Figure 1). 5 
The abundance of AQP2, NCC3, and PGT in UEVs from freshly collected urine was not 6 
significantly different to urine which had been stored at -80oC with protease inhibitor 7 
(Supplementary Figure 1); however AQP2 and NCC3 abundance was significantly less 8 
in the UEVs of urine stored at -200C compared to that from urine stored at -800C. 9 
(Supplementary Figure 2).  10 
 11 
 12 
Figure 1: Western blot analysis of AQP2, NCC3 and PGT in different urinary 13 
fractions demonstrates expression predominantly in urinary extracellular 14 
vesicles. Abundance of AQP2 (A), NCC3 (B) and PGT (C) are shown in Urinary 15 
Extracellular vesicles (UEVs), Cell Pellet (CP) and Total Urine (TU) fractions. Blots 16 
shown are representative of individual experiments. N=8 in each group. Data are 17 
corrected for exosomal expression of ALIX and are shown as mean ± SEM. ****p < 18 
0.0001.  19 
 20 
Expression of UEVs AQP2, NCC and PGT in TIH 21 
 22 
The clinical characteristics of TIH patients and controls are shown in Supplementary 23 
Table 1. UEV AQP2 was significantly more abundant in acutely hyponatremic TIH cases 24 
on thiazides compared to normonatremic control patients on or off thiazides (Figure 2A). 25 
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Even when TIH cases had recovered to normonatremia, AQP2 expression was still 1 
greater than controls (Figure 2A).  2 
 3 
UEV NCC3 and NCC1&2 were significantly less abundant in acutely hyponatremic TIH 4 
cases on thiazides compared to convalescent normonatremic TIH cases off thiazides 5 
and normonatremic controls on or off thiazides (Figure 2B and 2C). Although NCC 6 
abundance increased in TIH cases on recovery to normonatremia off thiazides, NCC 7 
expression was still 30% less than normonatremic controls off thiazide (Figure 2B and 8 
2C).  9 
 10 
Extracellular vesicle  ProstaGlandin Transporter (PGT) was significantly more abundant 11 
in acutely hyponatremic TIH cases on thiazides compared to normonatremic controls on 12 
thiazides. Despite reduction in PGT in TIH cases following cessation of thiazide and 13 
recovery to normonatremia, PGT expression was still significantly greater than 14 
normonatremic controls off thiazides (Figure 2D).  15 
 16 
We also used a second method of UEVs analysis (Nanoparticle Tracking Analysis, 17 
NTA) to analyse differences in NCC3 and AQP2 excretion between these patient groups. 18 
NTA has been used previously to quantify the abundance of UEVs containing AQP225 19 
and NCC326 in unprocessed urine samples. NTA analysis in our study showed that TIH 20 
patients had increased numbers of AQP2 positive UEVs in both acutely hyponatremic 21 
and convalescent normonatremic states compared to controls (Supplementary Figure 22 
3). The numbers of NCC3 positive UEVs were not significantly different between the 23 
groups. NTA analysis confirmed the changes in AQP2 expression in TIH patients seen 24 
by Western blot analysis.  25 
 26 
 27 
 28 
 29 
 30 
 31 
 32 
 33 
 34 
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 1 
 2 
Figure 2: Western blot analysis of AQP2, NCC and PGT in patients with TIH and 3 
controls. Abundance of UEV (A) AQP2, (B) NCC3 (C) NCC1&2 and (D) PGT are shown. 4 
Blots shown are representative of individual experiments. Data are corrected for 5 
exosomal expression of ALIX and are shown as mean ± SEM. *p <0.05; **p < 0.01; ***p 6 
< 0.001. Hyponatremic TIH cases on thiazides (HC) n=8, normonatremic TIH cases off 7 
thiazides (NC) n=16, normonatremic thiazide controls (TC) n=16 and normonatremic 8 
non-thiazide controls (NTC) n=16. 9 
 10 
Assessment of NCC phosphorylation at three principal N-terminal locations known to 11 
accelerate transporter kinetics (T55, T60 and S91) was undertaken. Patients acutely 12 
hyponatremic on thiazides with TIH displayed significantly greater phosphorylation at 13 
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T55, T60 and S91 than either convalescent normonatremic TIH cases off thiazides or 1 
normonatremic controls on thiazides (Figure 3).  2 
 3 
 4 
Figure 3: Western blot analysis of N-terminal NCC phosphorylation in TIH : Abundance 5 
of UEV NCC phosphorylation at (A) T60, (B) T55 and (C) S91 is shown in acute TIH cases, 6 
convalescent TIH cases, and controls on and off thiazide respectively. Blots shown are 7 
representative of individual experiments. Data are corrected for exosomal expression of ALIX 8 
and are shown as mean ± SEM. * p < 0.05, **p < 0.01, ***p < 0.001. Hyponatremic TIH cases 9 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
11 
 
on thiazides (HC) n=8, Normonatremic TIH cases off thiazides (NC) n=16, Normonatremic 1 
thiazide controls (TC) n=16 and normonatremic non-thiazide controls (NTC) n=16. 2 
 3 
Endogenous Lithium clearance in TIH 4 
Renal Endogenous Lithium Clearance (ELC) was lower in acutely hyponatremic TIH 5 
cases on thiazides compared to convalescent TIH cases on recovery to normonatremia 6 
following thiazide cessation (Figure 4). ELC was also lower in acutely hyponatremic TIH 7 
cases compared to normonatremic controls on thiazide (Figure 4). 8 
                                                                                                                                                              9 
 10 
Figure 4: Renal Endogenous Lithium Clearance (ELC) is reduced in acute TIH. 11 
ELC was lower in hyponatremic TIH cases on thiazides compared to either the 12 
normonatremic TIH cases off thiazides or normonatremic thiazide controls. N=7 in each 13 
group. Data represented as mean ± SEM. * p < 0.05, **p < 0.01.  14 
 15 
Discussion 16 
Here we report a non-invasive method of obtaining, preserving and analysing urinary 17 
extracellular vesicles from volunteer patients suffering from Thiazide Induced 18 
Hyponatremia who were admitted to an acute internal medicine department. In addition, 19 
analysis of distal nephron sodium, water and prostaglandin transporters contained 20 
within the extracellular vesicles suggests a possible mechanism which may underlie the 21 
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pathophysiology of TIH. These data add to what has been previously been reported18 1 
by demonstrating that patients with acute TIH display reduced total NCC and increased 2 
phospho-NCC and AQP2 in their UEVs relative to appropriate control groups. 3 
 4 
We have shown that the extracellular vesicles fraction is the most appropriate 5 
component of human urine in which to study the expression of NCC, AQP2 and PGT. 6 
Further we demonstrate that it is not necessary to analyse only fresh urine samples and 7 
that samples frozen with protease inhibitor are equally suitable for use. This is important 8 
since if analysis was limited to fresh samples, the time consuming sample processing 9 
and immediate exosome isolation would make the study of acute medical conditions 10 
such as TIH very difficult. Since acquisition of a spot urine sample, addition of protease 11 
inhibitor tablet and storage in a freezer can be performed by the majority of clinical and 12 
research staff with very limited training required, such sample acquisition from acute 13 
medical patients becomes a much more feasible proposition.   14 
 15 
A priori TIH must result from excessive saliuresis and/or water reabsorption. As thiazide 16 
diuretics have not been observed to produce saliuresis with urinary sodium 17 
concentration greater than plasma, excess water reabsorption (or ingestion) is likely to 18 
be a fundamental part of TIH pathophysiology. Reduced renal expression of NCC and 19 
increased expression of AQP2 in acute TIH would support the hypothesis that the 20 
pathophysiology of TIH results from a combination of both of these processes. We have 21 
successfully identified both NCC1&2, NCC3 and determined the phosphorylation status 22 
of three key N terminal phosphorylation sites known to regulate NCC activity from the 23 
urinary extracellular vesicles. In addition reduced Endogenous Lithium Clearance (ELC) 24 
in acute TIH supports increased proximal sodium reabsorption reflecting augmented 25 
distal nephron sodium loss and so is complementary to the UEV data.  26 
 27 
The increased N-terminal phosphorylation state of NCC in acute TIH suggests some 28 
degree of physiological compensation to excessive distal nephron sodium loss, by 29 
attempting to maximally activate what NCC exists in the DCT. Why type 1 regulation of 30 
NCC (apical membrane expression) should be impaired in TIH but type 2 regulation 31 
(transporter activation by N terminal phosphorylation) remain intact is unclear. It is 32 
notable that thiazides inhibit NCC by binding to the co-transporter from the luminal 33 
membrane and one hypothesis may be that the physical binding of thiazides to NCC in 34 
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induces a conformational change which targets the cotransporter for endocytosis and 1 
degradation in patients susceptible to TIH. Alternatively saliuresis and resulting 2 
kaliuresis and trend to hypokalemia seen in acute TIH patients may drive 3 
phosphorylation and activation of remaining NCC27. 4 
 5 
Thiazides reduce the ability of the late diluting segment (DCT) to generate solute-free 6 
water directly and also act by reducing effective vascular volume and thus solute 7 
delivery from the end-proximal tubule28. The increased proximal renal sodium 8 
reabsorption observed would support a reduction in the amount of fluid available to 9 
reach the diluting segments of the nephron, which is then further reduced by the role of 10 
thiazides and the observed reduction in NCC expression acting to reduce dilution. 11 
Study of NHE3 expression in the proximal tubule may therefore be informative for future 12 
studies.   13 
 14 
Measuring differences in the UEV profile of acutely hyponatremic patients may also 15 
have clinical utility as an aid to TIH diagnosis where other potential contributors to 16 
hyponatremia exist. The use of UEV analysis as a diagnostic tool would require further 17 
studies to identify whether acute differences in UEV profiling exist in other causes of 18 
hyponatremia and whether profiling of a panel of UEV markers could reliably 19 
differentiate one cause of hyponatremia from another. 20 
 21 
We chose also to study PGT since it is constitutively expressed in the CD where it 22 
mediates PGE2 uptake, one of the most important physiological regulators of distal 23 
nephron water reabsorption28. The protein-altering variant in SLCO2A1 (p.A396T), the 24 
gene which encodes PGT was also recently reported to show modest association with 25 
TIH18. Here we show that PGT is significantly expressed in UEVs and that PGT 26 
expression is substantially elevated in acute TIH. This provides further support that 27 
PGT may be involved in the molecular pathways causing inappropriate water 28 
reabsorption in TIH. 29 
 30 
That differences in the extracellular vesicle profile of convalescent normonatremic TIH 31 
cases exist two months after thiazides have been discontinued suggests that patients 32 
who are predisposed to TIH may exhibit these urinary extracellular vesicle  33 
characteristics before they were exposed to thiazides. Although a prospective study 34 
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would be required to confirm this observation, it raises the possibility that pre-1 
prescription profiling of the relative abundance of NCC to AQP2 could potentially identify 2 
patients at higher risk of TIH. These individuals could then be offered alternative anti-3 
hypertensive therapy, for example medicines from the ACE inhibitor or calcium channel 4 
antagonist groups or, if a diuretic was required, an alternative loop or potassium sparing 5 
type could be selected instead of a thiazide.  6 
 7 
In summary, we show here that TIH patients display reduced NCC expression and 8 
increased AQP2 expression in their UEVs which would be expected to produce 9 
excessive saliuresis and water resorption. Reduced ELC also suggests compensatory 10 
increased proximal sodium reabsorption in TIH. That differences in the renal 11 
transporters responsible for these processes can be detected in urinary extracellular 12 
vesicle both acutely and following recovery from TIH raises the possibility that such 13 
techniques may have utility in prospectively identifying those at high risk of TIH and in 14 
aiding the acute diagnosis of TIH in cases which are confounded by comorbidity and/ or 15 
polypharmacy. 16 
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2. Supplementary Figure 1: Western blotting of urinary extracellular vesicle demonstrates 21 
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fresh (F) vs. frozen (FR) urine. 23 
3. Supplementary Figure 2: Western blotting of urinary extracellular vesicle demonstrates 24 
that abundance of (A) AQP2 and (B) NCC is significantly different in urine stored at -25 
800C vs. -200C. 26 
4. Supplementary Figure 3: Nanoparticle Tracking Analysis. 27 
5. Supplementary Figure 4: Western blotting analysis of urinary extracellular vesicle (A) 28 
AQP2 (B) NCC and (C) PGT in TIH patients and controls. 29 
6. Supplementary Figure 5: Western blotting analysis of urinary extracellular vesicle 30 
pNCC (A) T60  (B) T55 and (C) S91 in TIH patients and controls. 31 
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